Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Workman

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
Cancer Treatment Reports|September 1, 1986
Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069P Workman
Seminars in Cancer Biology|December 1, 1992
Introduction: new anticancer drug design and discovery based on advances in molecular oncologyP Workman
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combinationP Workman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The cell membrane and cell signals: new targets for novel anticancer drugsP Workman
Oncology Research|January 1, 1994
Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphoraseP Workman
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics in experimental and clinical chemotherapyP Workman
Anti-Cancer Drug Design|November 20, 1997
Towards intelligent anticancer drug screening in the post-genome era?P Workman
The British Journal of Radiology|July 1, 1980
The neurotoxicity of misonidazole: potential modifying role of dexamethasoneP Workman
Biochemical Pharmacology|October 15, 1980
Drug interactions with misonidazole: effects of dexamethasone and its derivatives on the pharmacokinetics and toxicity of misonidazole in miceP Workman
Cancer Clinical Trials|January 1, 1980
Pharmacokinetics of hypoxic cell radiosensitizers: a reviewP Workman
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Cancer Treatment Reports|September 1, 1986
Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069P Workman
Seminars in Cancer Biology|December 1, 1992
Introduction: new anticancer drug design and discovery based on advances in molecular oncologyP Workman
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combinationP Workman
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The cell membrane and cell signals: new targets for novel anticancer drugsP Workman
Oncology Research|January 1, 1994
Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphoraseP Workman
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics in experimental and clinical chemotherapyP Workman
Anti-Cancer Drug Design|November 20, 1997
Towards intelligent anticancer drug screening in the post-genome era?P Workman
The British Journal of Radiology|July 1, 1980
The neurotoxicity of misonidazole: potential modifying role of dexamethasoneP Workman
Biochemical Pharmacology|October 15, 1980
Drug interactions with misonidazole: effects of dexamethasone and its derivatives on the pharmacokinetics and toxicity of misonidazole in miceP Workman
Cancer Clinical Trials|January 1, 1980
Pharmacokinetics of hypoxic cell radiosensitizers: a reviewP Workman
Pageof 27